Abstract
Background: Alzheimer’s disease (AD) is one of the most devastating diseases worldwide. The current drugs for AD can only ameliorate the symptoms rather than reverse or prevent the progress of AD. On the other hand, blood-brain barrier (BBB), as a natural barrier, significantly impedes drug delivery from the blood circulation into the brain. Nanomedicine can be a safe, effective and promising approach to treat AD.
Objective: This review summarizes the recent nanomedicine research in this area, including the use of liposomes and nanoparticles (NPs), to provide new approach for targeted treatment of AD.
Method: Collecting and referring to the related literature in recent 10 years, via searching MeSH Terms “Alzheimer's disease; nanomedicine; nanoparticle; amyloid β peptide; tau protein; autophagy”.
Results: Nanomedicines show superiority over conventional anti-AD drugs as a potential weapon against AD by the five proposed mechanisms: many unfavorable pharmaceutical properties of conventional anti-AD drugs maybe greatly overcome by nanomedicine; nanomedicines trigger efficient production of high-titer anti-Aβ antibodies following controlled release of antigens by them; some apolipoprotein- based nanomedicines could preferably bind to Aβ and increase the elimination of Aβ; nanomedicine-induced autophagy could be facilitated to increase the elimination of Aβ; nanomedicineinduced inhibition of tau aggregation.
Conclusion: Therefore, nanomedicine-mediated drug therapy is promising in the treatment of AD.
Keywords: Alzheimer`s disease, nanomedicine, nanoparticle, amyloid β peptide, tau protein, BBB.
Mini-Reviews in Medicinal Chemistry
Title:Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease
Volume: 18 Issue: 12
Author(s): Tian-Jun Ma , Jie Gao, Yan Liu, Jian-Hua Zhuang, Chuan Yin, Peng Li, Lei Mao, Jin Xu , Yi-Xin Xu, Yan-Peng Li , Zhong-Xin Zhao and You Yin*
Affiliation:
- Department of Neurology, Changzheng Hospital, Second Military Medical University, Shanghai 200003,China
Keywords: Alzheimer`s disease, nanomedicine, nanoparticle, amyloid β peptide, tau protein, BBB.
Abstract: Background: Alzheimer’s disease (AD) is one of the most devastating diseases worldwide. The current drugs for AD can only ameliorate the symptoms rather than reverse or prevent the progress of AD. On the other hand, blood-brain barrier (BBB), as a natural barrier, significantly impedes drug delivery from the blood circulation into the brain. Nanomedicine can be a safe, effective and promising approach to treat AD.
Objective: This review summarizes the recent nanomedicine research in this area, including the use of liposomes and nanoparticles (NPs), to provide new approach for targeted treatment of AD.
Method: Collecting and referring to the related literature in recent 10 years, via searching MeSH Terms “Alzheimer's disease; nanomedicine; nanoparticle; amyloid β peptide; tau protein; autophagy”.
Results: Nanomedicines show superiority over conventional anti-AD drugs as a potential weapon against AD by the five proposed mechanisms: many unfavorable pharmaceutical properties of conventional anti-AD drugs maybe greatly overcome by nanomedicine; nanomedicines trigger efficient production of high-titer anti-Aβ antibodies following controlled release of antigens by them; some apolipoprotein- based nanomedicines could preferably bind to Aβ and increase the elimination of Aβ; nanomedicine-induced autophagy could be facilitated to increase the elimination of Aβ; nanomedicineinduced inhibition of tau aggregation.
Conclusion: Therefore, nanomedicine-mediated drug therapy is promising in the treatment of AD.
Export Options
About this article
Cite this article as:
Ma Tian-Jun , Gao Jie , Liu Yan, Zhuang Jian-Hua, Yin Chuan , Li Peng , Mao Lei , Xu Jin , Xu Yi-Xin, Li Yan-Peng , Zhao Zhong-Xin and Yin You *, Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease, Mini-Reviews in Medicinal Chemistry 2018; 18 (12) . https://dx.doi.org/10.2174/1389557518666171215150024
DOI https://dx.doi.org/10.2174/1389557518666171215150024 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanotechnology in Neuroscience and its Perspective as Gene Carrier
Current Topics in Medicinal Chemistry The Delivery of Personalised, Precision Medicines <i>via</i> Synthetic Proteins
Drug Delivery Letters Modulation of MicroRNAs by <i>Euphorbia Microsciadia</i> Boiss in MDA-MB-231 Cell Line: New Possibilities in Breast Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Current Pharmaceutical Design De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics
Current Pharmaceutical Design Liposome-Encapsulated Photosensitizers Against Bacteria
Recent Patents on Anti-Infective Drug Discovery Fighting Fire with Fire: A Patent for the Combined Application of Oncolytic Herpes Viruses and Antiangiogenic Agents in the Battle Against Human Cancers
Recent Patents on Anti-Cancer Drug Discovery Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Viral Based Gene Therapy for Prostate Cancer
Current Gene Therapy Microwave Assisted Synthesis, Biological Characterization and Docking Studies of Pyrimidine Derivatives
Current Microwave Chemistry Aminophosphonate Metal Complexes of Biomedical Potential
Current Medicinal Chemistry Injectable Thermosensitive Chitosan/Glycerophosphate-Based Hydrogels for Tissue Engineering and Drug Delivery Applications: A Review
Recent Patents on Drug Delivery & Formulation A Nanostructured Silica-Lipid Hybrid to Facilitate Oral SN-38-based Chemotherapy
Drug Delivery Letters Imaging Tumor Metastases with Molecular Probes
Current Pharmaceutical Design The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
Current Cancer Drug Targets Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update
Current Topics in Medicinal Chemistry Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Applications of Nanosystems to Anticancer Drug Therapy (Part I. Nanogels, Nanospheres, Nanocapsules)
Recent Patents on Anti-Cancer Drug Discovery Cannabis-Derived Substances in Cancer Therapy – An Emerging Anti- Inflammatory Role for the Cannabinoids
Current Clinical Pharmacology